Yang Feng

NPM1 mutation mediated HOXBLINC lncRNA activation promotes AML leukemogenesis

O. Guryanova, Wei Li, Bing Xu, 2020 .

T-cell exhaustion in immune-mediated inflammatory diseases: New implications for immunotherapy

Jun Liang, Yang Feng, Z. Gao, 2022, Frontiers in Immunology.

DNMT3A alterations associated with myeloid malignancies dictate differential responses to hypomethylating agents.

O. Guryanova, Jianping Li, Yang Feng, 2020, Leukemia research.

HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia

R. Mesa, S. Nimer, O. Guryanova, 2021, Nature Communications.

Alterations to DNMT3A in Hematologic Malignancies

O. Guryanova, Yang Feng, Daniil E. Shabashvili, 2020, Cancer Research.

Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer

A. Riva, R. Levine, W. Chatila, 2022, bioRxiv.

DNMT3A Harboring Leukemia-Associated Mutations Directs Sensitivity to DNA Damage at Replication Forks

J. Licht, A. Riva, P. Staber, 2021, bioRxiv.

miR-196b-TLR7/8 signaling axis regulates innate immune signaling and myeloid maturation in DNMT3A-mutant AML.

O. Guryanova, Sara E. Meyer, N. Palmisiano, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer

A. Riva, R. Levine, W. Chatila, 2023, The Journal of experimental medicine.

Cells with DNMT3A Mutations Are More Sensitive to Cytarabine-Induced DNA Damage

J. Licht, O. Guryanova, Jianping Li, 2018, Blood.

Gemcitabine resistance in breast cancer cells regulated by PI3K/AKT-mediated cellular proliferation exerts negative feedback via the MEK/MAPK and mTOR pathways

Z. Ou, Z. Shao, Juan Lin, 2014, OncoTargets and therapy.